Chemical Compound Review:
Serentil 10-[2-(1-methyl-2- piperidyl)ethyl]-2...
Synonyms:
Calodal, Lidanar, Lidanil, Mesoridazina, mesoridazine, ...
- Mesoridazine use and priapism. Starck, L.C., Talley, B.J., Brannan, S.K. The American journal of psychiatry. (1994)
- Complete heart block associated with mesoridazine and lithium combination. Salama, A.A. The Journal of clinical psychiatry. (1987)
- Schizophrenia, antipsychotic drugs, and cardiovascular disease. Glassman, A.H. The Journal of clinical psychiatry. (2005)
- Cardiotoxic manifestations of mesoridazine overdose. Marrs-Simon, P.A., Zell-Kanter, M., Kendzierski, D.L., Leikin, J.B. Annals of emergency medicine. (1988)
- Plasma and red cell levels of thioridazine and clinical response in schizophrenia. Smith, R.C., Baumgartner, R., Ravichandran, G.K., Shvartsburd, A., Schoolar, J.C., Allen, P., Johnson, R. Psychiatry research. (1984)
- Mesoridazine (Serentil) in personality disorders--a controlled trial in adolescent patients. Barnes, R.J. Diseases of the nervous system. (1977)
- Mesoridazine in Huntington's disease (chorea): effect on weight, dyskinesia, and mental function. Drymiotis, A., Korenyi, C., Whittier, J.R. Current therapeutic research, clinical and experimental. (1976)
- A unitary mechanism of calcium antagonist drug action. Murphy, K.M., Gould, R.J., Largent, B.L., Snyder, S.H. Proc. Natl. Acad. Sci. U.S.A. (1983)
- Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients. Shvartsburd, A., Sajadi, C., Morton, V., Mirabi, M., Gordon, J., Smith, R.C. Journal of clinical psychopharmacology. (1984)
- Mesoridazine: an open-channel blocker of human ether-a-go-go-related gene K+ channel. Su, Z., Martin, R., Cox, B.F., Gintant, G. J. Mol. Cell. Cardiol. (2004)
- D4 dopamine receptor binding affinity does not distinguish between typical and atypical antipsychotic drugs. Roth, B.L., Tandra, S., Burgess, L.H., Sibley, D.R., Meltzer, H.Y. Psychopharmacology (Berl.) (1995)
- Single dose kinetics of thioridazine and its two psychoactive metabolites in healthy humans: a dose proportionality study. Chakraborty, B.S., Midha, K.K., McKay, G., Hawes, E.M., Hubbard, J.W., Korchinski, E.D., Choc, M.G., Robinson, W.T. Journal of pharmaceutical sciences. (1989)
- Studies on thioridazine and mesoridazine metabolism. I. Protein binding. Forrest, I.S., Green, D.E., Blum, A., Serra, M.T., Loeffler, K.O. Communications in psychopharmacology. (1979)
- Red blood cell and plasma levels of thioridazine and mesoridazine in schizophrenic patients. Shvartsburd, A., Nwokeafor, V., Smith, R.C. Psychopharmacology (Berl.) (1984)
- Effect of thioridazine on gap junction intercellular communication in connexin 43-expressing cells. Matesic, D.F., Abifadel, D.N., Garcia, E.L., Jann, M.W. Cell Biol. Toxicol. (2006)
- A fixed dose study of the plasma concentration and clinical effects of thioridazine and its major metabolites. Cohen, B.M., Lipinski, J.F., Waternaux, C. Psychopharmacology (Berl.) (1989)
- Mesoridazine and human sleep. Adam, K., Allen, S., Carruthers-Jones, I., Oswald, I., Spence, M. British journal of clinical pharmacology. (1976)
- Development of a radioimmunoassay procedure for mesoridazine and its comparison with a high-performance liquid chromatographic method. Chakraborty, B.S., Hawes, E.M., Midha, K.K. Therapeutic drug monitoring. (1987)
- Dysphoric response to neuroleptics as a predictor of treatment outcome with schizophrenics. A comparative study of haloperidol versus mesoridazine. White, K., Busk, J., Eaton, E., Gomez, G., Razani, J., Sloane, R.B. International pharmacopsychiatry. (1981)
- Synthesis, receptor binding and functional studies of mesoridazine stereoisomers. Choi, S., Haggart, D., Toll, L., Cuny, G.D. Bioorg. Med. Chem. Lett. (2004)
- Use of the mesoridazine/thioridazine ratio as a marker for CYP2D6 enzyme activity. Llerena, A., Berecz, R., de la Rubia, A., Norberto, M.J., Benítez, J. Therapeutic drug monitoring. (2000)
- Synthesis and properties of haptens for the development of radioimmunoassays for thioridazine, mesoridazine, and sulforidazine. Chakraborty, B.S., Sardessai, M.S., Jaworski, T.J., Midha, K.K., Hawes, E.M. Pharm. Res. (1987)
- Degradation and configurational changes of thioridazine 2-sulfoxide. de Gaitani, C.M., Martinez, A.S., Bonato, P.S. Journal of pharmaceutical and biomedical analysis. (2004)